Retry at chart low imminent, rise pending. I am in.Hope some of you looked closely at AUM & AUMO when I mentioned them on 8/6/2006 for another iron in the fire.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%